First trial of gene therapy for advanced heart failure shows promising results

November 11, 2008

Phase I results of the first clinical trial of gene therapy for patients with advanced heart failure show the approach to be promising, with improvements in several measures of the condition's severity.

In Phase I clinical trials, researchers test a new treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.

Patients enrolled in the multicenter CUPID trial (Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease) undergo a minimally invasive cardiac catheterization procedure which introduces a specially engineered gene that stimulates production of an enzyme necessary for the heart to pump more efficiently.

NewYork-Presbyterian Hospital/Columbia University Medical Center was the first to offer the therapy in the New York City area. The Hospital is now recruiting patients for the Phase II CUPID trial to further assess safety and effectiveness in patients with advanced heart failure.

Data from the Phase I trial, which was initiated in May of 2007, were presented at the American Heart Association (AHA) Scientific Sessions 2008 in New Orleans yesterday. Seven of nine patients who were given the drug showed improvements over six months in several areas: symptomatic (five patients), functional (four patients), biomarker (two patients) and left ventricular function/remodeling (six patients). Two patients with pre-existing antibodies to the viral vector delivery system did not show improvements. Importantly, the approach was shown to have an acceptable safety profile, as determined by an independent safety committee and by the study investigators.

"We are encouraged by these initial findings, which indicate that this therapy has the potential to help patients with advanced heart failure," says Dr. Donna Mancini, the study's principal investigator at NewYork-Presbyterian Hospital/Columbia University Medical Center, where she is medical director of cardiac transplantation and is professor of medicine at Columbia University College of Physicians and Surgeons.

The Phase II randomized, double-blind, placebo-controlled clinical trial will compare the therapy at two- or three-dose levels with placebo. CUPID is expected to enroll 46 patients with advanced heart failure at 13 U.S. hospitals.

Gene therapy is a technique for correcting defective genes responsible for disease development by inserting genes into a patient's cells and tissues. In most gene therapy studies, a "normal" gene is inserted into the genome to replace an "abnormal" disease-causing gene. A carrier molecule called a vector must be used to deliver the therapeutic gene to the patient's target cells. Currently, one of the most common vectors is a non-pathogenic virus most people have been exposed to in adolescence that has been genetically altered to carry normal human DNA.

More than 5 million people in the U.S. have heart failure. Patients with severe form of the disease have trouble breathing because the heart muscle is not strong enough to pump fluid out of their lungs. Approximately 70 percent die of the disease within 10 years, and the five-year survival rate is less than 50 percent. Heart failure is the only cardiovascular disease whose incidence has been increasing rather than decreasing in recent years.

New York- Presbyterian Hospital/Columbia University Medical Center

Heart Failure: A Companion to Braunwald's Heart Disease: Expert Consult - Online and Print, 2e (Expert Consult Title: Online + Print)
by Douglas L. Mann MD FACC (Author)

Dr. Douglas L. Mann, one of the foremost experts in the field, presents the 2nd Edition of Heart Failure: A Companion to Braunwald's Heart Disease. This completely reworked edition covers the scientific and clinical guidance you need to effectively manage your patients and captures the dramatic advances made in the field over the last five years. Now in full color and with convenient online access, this edition features eleven new chapters, including advanced cardiac imaging techniques, use of biomarkers, cell-based therapies and tissue engineering, device therapies, and much more. Includes access to the complete contents online, fully searchable, enabling you to consult it rapidly from any computer with an Internet connection.
Incorporates an enhanced emphasis on surgical outcomes to...

The Cleveland Clinic Guide to Heart Failure (Cleveland Clinic Guides)
by Randall Starling (Author)

Expert medical advice from the #1 heart center in America for 14 years in a rowFor the 5 million people with heart failure, there’s new reason for hope: recent medical advances have revolutionized how this condition is managed.In The Cleveland Clinic Guide to Heart Failure, Dr. Randall Starling, one of the foremost authorities on heart health, provides authoritative advice to help people survive heart failure and enjoy a good quality of life. This comprehensive resource gives readers the cutting-edge medical guidance Dr. Starling offers his patients, including:
Insight into what causes heart failure;
The latest breakthrough studies – and what those discoveries mean for the future of this disease;
Reliable guidance on diagnostic tests and treatment options;
Personal...

Heart Failure in Clinical Practice
by Michael Y. Henein (Editor)

Heart Failure in Clinical Practice provides a toolkit for clinicians to guide them in the diagnosis and treatment of patients with suspected heart failure. Algorithms and flow diagrams are included to give the reader an illustrated snapshot of the decisions involved in the management of these patients.

Mechanical Circulatory Support Therapy in Advanced Heart Failure
by Mario C. Deng (Author), Yoshifumi Naka (Author)

This engaging book provides a state-of-the-art introduction to the rapidly evolving field of mechanical circulatory support therapy in the care of patients with advanced heart failure. It is aimed at healthcare teams around the world who are involved in patient care, research, and teaching of advanced heart failure; healthcare professionals in training; and interested lay persons. In particular, this book * serves as a comprehensive resource and practice guide on all aspects of mechanical circulatory support therapy, starting with an overview on heart failure management and then continuing with the referral and evaluation, the care before and after mechanical circulatory support implantation, the analysis of outcomes and complications, as well as a description of research and societal...

Oxford Textbook of Heart Failure (Oxford Textbooks in Cardiology)
by Theresa A. McDonagh (Author), Roy S. Gardner (Author), Andrew L. Clark (Author), Henry Dargie (Author)

Although the incidence of coronary heart disease is falling, its major complication, heart failure, is increasing in frequency. All health care practitioners will encounter patients with heart failure, presenting either acutely or in need of chronic heart failure management. However with recent advances in medical therapy, the prognosis of the condition has improved dramatically so that whereas once heart failure was a pre-terminal diagnosis, now for many it is treatable.

Taking the reader from an understanding of the basic mechanisms of heart failure through to an appreciation of the complexities of heart failure management and the remarkable improvements possible with good treatment, this definitive textbook is written by internationally renowned leaders in their field and...

Drug Treatment of Heart Failure
by Jay N. Cohn (Author)

Success with Heart Failure (mass mkt ed): Help and Hope for Those with Congestive Heart Failure
by Marc Silver (Author)

Up-to-date information on available and forthcoming medical and surgical treatments. How attitude and emotion affect heart failure-and what you can do to stay positive. Tips for adopting a heart-healthy diet and lifestyle. Ways to forge a positive working relationship with your doctor or cardiologist.

Heart Failure: From Advanced Disease to Bereavement (Oxford Specialist Handbooks in End of Life Care)
by Miriam Johnson (Author), Karen Hogg (Author), James Beattie (Author), Max Watson (Author)

Excellent end of life care for people with heart failure is challenging but possible. Failure to address this aspect of care has serious consequences for patients, their families, clinicians and the use of health resources.

Heart Failure: From Advanced Disease to Bereavement illustrates the complexity and importance of end of life care for patients with advanced heart failure.

This book is a pocket reference for everyday use in the clinic, ward or home visit for all doctors, nurses and AHPs caring for people with advanced heart failure.

It outlines the underlying pathophysiology of heart failure, summarises standard pharmacological and device therapy, and sets the context of the challenges resulting from an unpredictable course of disease. In easily digestible...

ABC of Heart Failure (ABC Series)
by Russell C. Davis (Author), Michael K. Davies (Author), Gregory Y. H. Lip (Author)

This new edition of the ABC of Heart Failure provides coherent and concise information relating to the epidemiology, pathophysiology and clinical features, aiding the diagnosis and treatment of this life threatening condition.

Fully updated to cover all the latest advances, the ABC of Heart Failure is an invaluable reference for general practitioners, hospital doctors, nurses and other healthcare professionals involved in the treatment and prevention of heart failure.

Manual of Heart Failure Management
by John D. Bisognano (Editor), Marc L. Baker (Editor), Mary Beth Earley (Editor)

Practical simple reference for understanding current management of heart failure Provides pathophysiology and pharmacology to explain the key points Focuses mostly on patient management issues